Financials data is unavailable for this security.
View more
Year on year Hetzer Medical Indonesia Tbk PT 's revenues fell -39.79% from 37.74bn to 22.72bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 237.06m to a loss of 3.57bn.
| Gross margin | 59.04% |
|---|---|
| Net profit margin | -12.07% |
| Operating margin | -6.94% |
| Return on assets | -2.84% |
|---|---|
| Return on equity | -3.44% |
| Return on investment | -3.18% |
More ▼
Cash flow in IDRView more
In 2023, cash reserves at Hetzer Medical Indonesia Tbk PT fell by 4.70bn. However, the company earned 3.15bn from its operations for a Cash Flow Margin of 13.87%. In addition the company used 6.09bn on investing activities and also paid 1.76bn in financing cash flows.
| Cash flow per share | 1.67 |
|---|---|
| Price/Cash flow per share | 29.91 |
| Book value per share | 38.16 |
|---|---|
| Tangible book value per share | 38.16 |
More ▼
Balance sheet in IDRView more
| Current ratio | 3.82 |
|---|---|
| Quick ratio | 1.48 |
| Total debt/total equity | 0.0978 |
|---|---|
| Total debt/total capital | 0.0891 |
More ▼
Growth rates in IDR
Year on year, growth in earnings per share excluding extraordinary items dropped -1,423.78%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 81.13 |
